WO2021104777A1 - Active substance combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates, and cosmetic or dermatological preparations containing such active substance combinations - Google Patents

Active substance combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates, and cosmetic or dermatological preparations containing such active substance combinations Download PDF

Info

Publication number
WO2021104777A1
WO2021104777A1 PCT/EP2020/080057 EP2020080057W WO2021104777A1 WO 2021104777 A1 WO2021104777 A1 WO 2021104777A1 EP 2020080057 W EP2020080057 W EP 2020080057W WO 2021104777 A1 WO2021104777 A1 WO 2021104777A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
phosphate
emulsifiers
cosmetic
preparations
Prior art date
Application number
PCT/EP2020/080057
Other languages
German (de)
French (fr)
Inventor
Sebastian Rosenbaum
Thomas Raschke
Sabrina Breitkreutz
Helga Biergiesser
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2021104777A1 publication Critical patent/WO2021104777A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Definitions

  • the present invention relates to cosmetic and dermatological preparations with an effective content of physiologically compatible active ingredient combinations, preferably those which are used in skin care cosmetic or dermatological preparations.
  • antioxidants are used as protective substances against spoilage of the preparations containing them. Nevertheless, it is known that undesirable oxidation processes can also occur in human and animal skin. Such processes play an essential role in skin aging.
  • antioxidants and radical scavengers are known.
  • US Patents 4,144,325 and 4,248,861 as well as numerous other documents, suggest using vitamin E, a substance with a known antioxidant effect, in light protection formulations, but here too the effect achieved remains far below the hoped-for effect.
  • One object of the present invention was to eliminate the disadvantages of the prior art.
  • active ingredients or preparations containing such active ingredients should be made available, if they are used, damage to the skin and / or hair due to oxidative influence can at least be reduced, if not completely prevented.
  • Another object of the present invention was to provide cosmetic preparations which, before or after treatment of the hair with hair coloring preparations, even those containing strong oxidizing agents such as hydrogen peroxide, counteract their damaging oxidizing effect.
  • Ubiquinols are characterized by the following chemical structure:
  • n 10 predominates (ubidecarenol), which according to the invention is the preferred ubiquinol.
  • ubiquinols The cosmetic use of ubiquinols is known per se, for example from WO 2017/045034, DE 42 28 871 and other publications.
  • ubiquinol in particular ubidecarenol
  • ubidecarenol is very sensitive to water and oxygen and is therefore preferably presented in anhydrous preparations, and is preferably also stored in the absence of air or in the presence of antioxidants. Apart from the fact that the active ingredient as such is lost during the oxidation of the active ingredient, the preparation turns yellowish or even brownish in the course of a short time.
  • Preparations in particular O / W emulsions containing one or more phosphate emulsifiers, stabilize ubidecarenol significantly better than other, comparable preparations.
  • Embodiments of the present invention preferred according to the invention are characterized in that the phosphate emulsifier is one or more from the group triceteareth-4 phosphate, cetyl phosphate, lecithin, hydrogenated lecithin, potassium cetyl phosphate, trilaureth-4 phosphate, laureth-4 phosphate, sodium dihydroxycetyl phosphate , Trioleth-8 Phos phate is chosen.
  • Embodiments of the present invention which are likewise preferred according to the invention are characterized in that sodium cetearyl sulfate is selected as the sulfate emulsifier.
  • molar ratio of ubidecarenol on the one hand to the molar sum of one or more phosphate emulsifiers or sulfate emulsifiers on the other hand from the range from 100: 1 to 1: 1000, preferably 50: 1 to 1: 500, especially preferably 20: 1 up to 1: 200 to be selected.
  • the preparations are particularly advantageously characterized in that ubidecarenol, in concentrations of 0.001-10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-3.00% by weight, %, based in each case on the total weight of the composition, is present.
  • the preparations are particularly advantageously characterized in that one or more phosphate emulsifiers in concentrations of a total of 0.001 - 10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-3.00% by weight, each based on the total weight of the composition, is or are present.
  • the preparations are furthermore particularly advantageously characterized in that one or more sulfate emulsifiers in total concentrations of 0.001-1.00% by weight, preferably 0.05-0.50% by weight, particularly preferably 0.10% by weight,
  • the cosmetic or dermatological formulations according to the invention can have the usual composition and serve for the treatment, care and cleaning of the skin and / or hair and as a make-up product in decorative cosmetics. They contain preferably 0.01% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2.0% by weight, based on the total weight of the agent, one or more active ingredient combinations according to the invention.
  • the cosmetic and dermatological preparations according to the invention are applied to the skin and / or hair in a sufficient amount in the manner customary for cosmetics.
  • the active ingredient combinations according to the invention can advantageously be incorporated into customary cosmetic and dermatological preparations, which can be in various forms. So you can z. B. a solution, an emulsion of the water-in-oil (W / O) type or of the oil-in-water (O / W) type, or a multiple emulsions, for example of the water-in-oil-in-water type (W / O / W) or oil-in-water-in-oil (O / W / O), a hydrodispersion or lipodispersion, a Pickering emulsion, a gel, a solid stick or an aerosol.
  • Emulsions according to the invention for the purposes of the present invention are advantageous and contain z.
  • Medical topical compositions for the purposes of the present invention generally contain one or more medicaments in effective concentrations.
  • cosmetic or topical dermatological compositions within the meaning of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sun protection lotion, nutritional cream, day or night cream, etc. It is optionally possible and advantageous to use the compositions according to the invention as a basis for to use pharmaceutical formulations.
  • the cosmetic and dermatological preparations are applied according to the invention to the skin and / or hair in a sufficient amount in the manner customary for cosmetics.
  • Those cosmetic and dermatological preparations which are in the form of a sunscreen agent are particularly preferred. These can advantageously also contain at least one further UVA filter and / or at least one further UVB filter and / or at least one inorganic pigment, preferably an inorganic micropigment.
  • the cosmetic and dermatological preparations can contain cosmetic auxiliaries such as are customarily used in such preparations, for example preservatives, bactericides, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, and moisturizers / or moisture-retaining substances, fats, oils, waxes or other common constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic auxiliaries such as are customarily used in such preparations, for example preservatives, bactericides, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, and moisturizers / or moisture-retaining substances, fats, oils, waxes or other common constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.
  • the amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight the preparation.
  • the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion
  • the following solvents can be used:
  • Oils such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, for example with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids;
  • Alcohols, diols or polyols with a low carbon number and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl ether or analogues Products.
  • mixtures of the abovementioned solvents are used.
  • water can be another component.
  • the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion
  • the following solvents can be used:
  • Oils such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerine, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids;
  • Alcohols, diols or polyols with a low carbon number and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl ether or analogues Products.
  • mixtures of the abovementioned solvents are used.
  • water can be another component.
  • Suitable propellants for cosmetic and / or dermatological preparations which can be sprayed from aerosol containers within the meaning of the present invention are the customary, highly volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be used alone or in a mixture with one another. It is also advantageous to use compressed air.
  • propellant gases which are nontoxic per se, which would be suitable in principle for the implementation of the present invention in the form of aerosol preparations, but which should nevertheless be avoided because of their harmful effects on the environment or other accompanying circumstances, in particular fluorocarbons and Chlorofluorocarbons (CFCs).
  • Cosmetic preparations within the meaning of the present invention can also be in the form of gels which, in addition to an effective content of active ingredient combinations according to the invention and solvents usually used for this, preferably water, also organic thickeners, e.g. gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, hydroxymethyl cellulose , Hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose or inorganic thickeners, e.g. B. aluminum silicates such as bentonite, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate contain.
  • the thickening agent is contained in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight.
  • the light protection formulations can advantageously contain further substances which absorb UV radiation in the UVB range, the total amount of the filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight. %, in particular 1 to 6% by weight, based on the total weight of the preparations, in order to provide cosmetic preparations which protect the skin from the entire range of ultraviolet radiation. They can also serve as sunscreens.
  • anionic O / W emulsifiers e.g. potassium cetearyl phosphate
  • anionic emulsifiers e.g. SLES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to active substance combinations which comprise a) ubidecarenol and b) one or more phosphate emulsifiers or sulfate emulsifiers.

Description

Beschreibung description
Wirkstoffkombinationen aus Ubichinol und einem oder mehreren Emulgatoren aus der Gruppe der Phosphate und Sulfate sowie kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend Active ingredient combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates and cosmetic or dermatological preparations containing such active ingredient combinations
Die vorliegende Erfindung betrifft kosmetische und dermatologische Zubereitungen mit ei nem wirksamen Gehalt an physiologisch verträglichen Wirkstoffkombinationen, bevorzugt solchen, welche in hautpflegenden kosmetischen oder dermatologischen Zubereitungen ein gesetzt werden. The present invention relates to cosmetic and dermatological preparations with an effective content of physiologically compatible active ingredient combinations, preferably those which are used in skin care cosmetic or dermatological preparations.
Hauptsächlich werden Antioxidantien als Schutzsubstanzen gegen den Verderb der sie ent haltenden Zubereitungen verwendet. Dennoch ist bekannt, dass auch in der menschlichen und tierischen Haut unerwünschte Oxidationsprozesse auftreten können. Solche Prozesse spielen eine wesentliche Rolle bei der Hautalterung. Mainly, antioxidants are used as protective substances against spoilage of the preparations containing them. Nevertheless, it is known that undesirable oxidation processes can also occur in human and animal skin. Such processes play an essential role in skin aging.
Im Aufsatz "Skin Diseases Associated with Oxidative Injury" in "Oxidative Stress in Der- matology", S. 323 ff. (Marcel Decker Inc., New York, Basel, Hong Kong, Herausgeber: Jür gen Fuchs, Frankfurt, und Lester Packer, Berkeley/Californien), werden oxidative Schäden der Haut und ihre näheren Ursachen aufgeführt. In the article "Skin Diseases Associated with Oxidative Injury" in "Oxidative Stress in Dermatology", p. 323 ff. (Marcel Decker Inc., New York, Basel, Hong Kong, editors: Jürgen Fuchs, Frankfurt, and Lester Packer , Berkeley / California), oxidative damage to the skin and its more detailed causes are listed.
Zwar sind einige Antioxidantien und Radikalfänger bekannt. So ist bereits in den US-Patent- schriften 4,144,325 und 4,248,861 sowie aus zahlreichen anderen Dokumenten vorgeschla gen worden, Vitamin E, eine Substanz mit bekannter antioxidativer Wirkung in Lichtschutz formulierungen einzusetzen, dennoch bleibt auch hier die erzielte Wirkung weit hinter der erhofften zurück. Some antioxidants and radical scavengers are known. For example, US Patents 4,144,325 and 4,248,861, as well as numerous other documents, suggest using vitamin E, a substance with a known antioxidant effect, in light protection formulations, but here too the effect achieved remains far below the hoped-for effect.
Eine Aufgabe der vorliegenden Erfindung war, die Nachteile des Standes der Technik zu beseitigen. Insbesondere sollten Wirkstoffe bzw. Zubereitungen, solche Wirkstoffe ent haltend, zur Verfügung gestellt werden, bei deren Verwendung die Schädigung der Haut und/oder des Haares durch oxidativen Einfluss zumindest gemindert, wenn nicht gänzlich verhindert werden können. Eine weitere Aufgabe der vorliegenden Erfindung bestand darin, kosmetische Zubereitungen zur Verfügung zu stellen, welche vor oder nach Behandlung des Haars mit Haarfär- bezubereitungen, selbst solcher mit einem Gehalt an starken Oxidationsmitteln wie z.B. Wasserstoffperoxid, deren schädigenden Oxidationswirkung entgegenwirken. One object of the present invention was to eliminate the disadvantages of the prior art. In particular, active ingredients or preparations containing such active ingredients should be made available, if they are used, damage to the skin and / or hair due to oxidative influence can at least be reduced, if not completely prevented. Another object of the present invention was to provide cosmetic preparations which, before or after treatment of the hair with hair coloring preparations, even those containing strong oxidizing agents such as hydrogen peroxide, counteract their damaging oxidizing effect.
Ubichinole bzw. deren oxidierte Form, die Ubichinone, spielen beim Elektronentransport in der Atmungskette von Lebewesen eine wichtige Rolle. Ubichinole sind durch folgende che mische Struktur gekennzeichnet:
Figure imgf000003_0001
Ubiquinols or their oxidized form, the ubiquinones, play an important role in the transport of electrons in the respiratory chain of living things. Ubiquinols are characterized by the following chemical structure:
Figure imgf000003_0001
In natürlich vorkommenden Ubichinolen bzw. deren oxidierter Form, den Ubichinonen, kann n Werte von 0 bis 50 annehmen. In Säugetieren insbesondere dem Menschen überwiegt n = 10 (Ubidecarenol), welches erfindungsgemäß das bevorzugte Ubichinol darstellt. In naturally occurring ubiquinols or their oxidized form, the ubiquinones, n can assume values from 0 to 50. In mammals, especially humans, n = 10 predominates (ubidecarenol), which according to the invention is the preferred ubiquinol.
An sich ist die kosmetische Verwendung von Ubichinolen bekannt, etwa aus der WO 2017/045034, der DE 42 28 871 und anderen Schriften. The cosmetic use of ubiquinols is known per se, for example from WO 2017/045034, DE 42 28 871 and other publications.
Ein Problem war aber, dass Ubichinol, insbesondere Ubidecarenol sehr wasser- und sauer stoffempfindlich ist und daher vorzugsweise in wasserfreien Zubereitungen dargeboten wird, bevorzugt auch unter Luftabschluss bzw. in der Gegenwart von Antioxidantien gelagert wird. Abgesehen davon, dass bei der Oxidation des Wirkstoffes der Wirkstoff als solcher verloren geht, verfärbt sich die Zubereitung im Laufe bereits kurzer Zeit gelblich oder gar bräunlich. One problem, however, was that ubiquinol, in particular ubidecarenol, is very sensitive to water and oxygen and is therefore preferably presented in anhydrous preparations, and is preferably also stored in the absence of air or in the presence of antioxidants. Apart from the fact that the active ingredient as such is lost during the oxidation of the active ingredient, the preparation turns yellowish or even brownish in the course of a short time.
Aufgabe der vorliegenden Erfindung war es also, diesem Problem Abhilfe zu schaffen. Es war überraschend und für den Fachmann nicht vorherzusehen, dass Wirkstoffkombinati onen umfassend a) Ubidecarenol b) einen oder mehrere Phosphatemulgatoren oder Sulfatemulgatoren bzw. kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Wirk stoffkombinationen die Lösung dieser Aufgaben darstellt und den Nachteilen des Standes der Technik abhelfen. The object of the present invention was therefore to remedy this problem. It was surprising and unforeseeable for the person skilled in the art that combinations of active ingredients comprising a) ubidecarenol b) one or more phosphate emulsifiers or sulfate emulsifiers or cosmetic or dermatological preparations containing such active ingredient combinations represents the solution to these problems and the disadvantages of the prior art remedy.
Zubereitungen, insbesondere O/W-Emulsionen mit einem Gehalt an einem oder mehreren Phosphatemulgatoren stabilisieren Ubidecarenol deutlich besser als andere, vergleichbare Zubereitungen. Preparations, in particular O / W emulsions containing one or more phosphate emulsifiers, stabilize ubidecarenol significantly better than other, comparable preparations.
Erfindungsgemäß bevorzugte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass als Phosphatemulgator ein oder mehrere aus der Gruppe Tricetea- reth-4 Phosphat, Cetylphosphat, Lecithin, hydriertes Lecithin, Kaliumcetylphosphat, Trilau- reth-4 Phosphat, Laureth-4 Phosphat, Sodium Dihydroxycetyl Phosphate, Trioleth-8 Phos phate gewählt wird. Embodiments of the present invention preferred according to the invention are characterized in that the phosphate emulsifier is one or more from the group triceteareth-4 phosphate, cetyl phosphate, lecithin, hydrogenated lecithin, potassium cetyl phosphate, trilaureth-4 phosphate, laureth-4 phosphate, sodium dihydroxycetyl phosphate , Trioleth-8 Phos phate is chosen.
Erfindungsgemäß ebenfalls bevorzugte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass als Sulfatemulgator Natriumcetearylsulfat gewählt wird. Embodiments of the present invention which are likewise preferred according to the invention are characterized in that sodium cetearyl sulfate is selected as the sulfate emulsifier.
Es ist erfindungsgemäß vorteilhaft, das molare Verhältnis von Ubidecarenol einerseits zu der molaren Summe eines oder mehrerer Phosphatemulgatoren oder Sulfatemulgatoren ande rerseits aus dem Bereich von 100 : 1 bis 1 : 1000 , bevorzugt 50 : 1 bis 1 : 500, insbesonde re bevorzugt 20 : 1 bis 1 : 200 zu wählen. It is advantageous according to the invention to set the molar ratio of ubidecarenol on the one hand to the molar sum of one or more phosphate emulsifiers or sulfate emulsifiers on the other hand from the range from 100: 1 to 1: 1000, preferably 50: 1 to 1: 500, especially preferably 20: 1 up to 1: 200 to be selected.
Erfindungsgemäß sind die Zubereitungen besonders vorteilhaft dadurch gekennzeichnet, dass Ubidecarenol, in Konzentrationen von 0,001 - 10,00 Gew.-%, bevorzugt 0,05 - 5,00 Gew.-%, besonders bevorzugt 0,1 - 3,00 Gew.-%, jeweils bezogen auf das Gesamt gewicht der Zusammensetzung, vorliegt. According to the invention, the preparations are particularly advantageously characterized in that ubidecarenol, in concentrations of 0.001-10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-3.00% by weight, %, based in each case on the total weight of the composition, is present.
Erfindungsgemäß sind die Zubereitungen besonders vorteilhaft dadurch gekennzeichnet, dass ein oder mehrere Phosphatemulgatoren in Konzentrationen von insgesamt 0,001 - 10,00 Gew.-%, bevorzugt 0,05 - 5,00 Gew.-%, besonders bevorzugt 0,1 - 3,00 Gew.-%, je weils bezogen auf das Gesamtgewicht der Zusammensetzung, vorliegt oder vorliegen. According to the invention, the preparations are particularly advantageously characterized in that one or more phosphate emulsifiers in concentrations of a total of 0.001 - 10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-3.00% by weight, each based on the total weight of the composition, is or are present.
Erfindungsgemäß sind die Zubereitungen darüber hinaus besonders vorteilhaft dadurch ge kennzeichnet, dass ein oder mehrere Sulfatemulgatoren in Konzentrationen von insgesamt 0,001 - 1,00 Gew.-%, bevorzugt 0,05 - 0,50 Gew.-%, besonders bevorzugt 0,10 — According to the invention, the preparations are furthermore particularly advantageously characterized in that one or more sulfate emulsifiers in total concentrations of 0.001-1.00% by weight, preferably 0.05-0.50% by weight, particularly preferably 0.10% by weight,
0,30 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, vorliegt oder vorliegen. 0.30% by weight, based in each case on the total weight of the composition, is or are present.
Die erfindungsgemäßen kosmetischen oder dermatologischen Formulierungen können wie üblich zusammengesetzt sein und zur Behandlung, der Pflege und der Reinigung der Haut und/oder der Haare und als Schminkprodukt in der dekorativen Kosmetik dienen. Sie enthal ten bevorzugt 0,01 Gew.-% bis 10 Gew.-%, bevorzugt 0,05 Gew.-% bis 5 Gew.-%, , insbe sondere 0,1 - 2,0 Gew.-%, bezogen auf das Gesamtgewicht des Mittels, an einer oder meh reren erfindungsgemäßen Wirkstoffkombinationen. The cosmetic or dermatological formulations according to the invention can have the usual composition and serve for the treatment, care and cleaning of the skin and / or hair and as a make-up product in decorative cosmetics. They contain preferably 0.01% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2.0% by weight, based on the total weight of the agent, one or more active ingredient combinations according to the invention.
Zur Anwendung werden die erfindungsgemäßen kosmetischen und dermatologischen Zu bereitungen in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausrei chender Menge aufgebracht. For use, the cosmetic and dermatological preparations according to the invention are applied to the skin and / or hair in a sufficient amount in the manner customary for cosmetics.
Vorteilhaft können die erfindungsgemäßen Wirkstoffkombinationen eingearbeitet werden in übliche kosmetische und dermatologische Zubereitungen, welche in verschiedenen Formen vorliegen können. So können sie z. B. eine Lösung, eine Emulsion vom Typ Wasser-in-ÖI (W/O) oder vom Typ Öl-in-Wasser (O/W), oder eine multiple Emulsionen, beispielsweise vom Typ Wasser-in-ÖI-in- Wasser (W/O/W) oder Öl-in-Wasser-in-ÖI (O/W/O), eine Hydrodi- spersion oder Lipodispersion, eine Pickering-Emulsion, ein Gel, einen festen Stift oder auch ein Aerosol darstellen. The active ingredient combinations according to the invention can advantageously be incorporated into customary cosmetic and dermatological preparations, which can be in various forms. So you can z. B. a solution, an emulsion of the water-in-oil (W / O) type or of the oil-in-water (O / W) type, or a multiple emulsions, for example of the water-in-oil-in-water type (W / O / W) or oil-in-water-in-oil (O / W / O), a hydrodispersion or lipodispersion, a Pickering emulsion, a gel, a solid stick or an aerosol.
Erfindungsgemäße Emulsionen im Sinne der vorliegenden Erfindung, z. B. in Form einer Creme, einer Lotion, einer kosmetischen Milch sind vorteilhaft und enthalten z. B. Fette, Öle, Wachse und/oder andere Fettkörper, sowie Wasser und einen oder mehrere Emulgatoren, wie sie üblicherweise für einen solchen Typ der Formulierung verwendet werden. Es ist auch möglich und vorteilhaft im Sinne der vorliegenden Erfindung, die erfindungsge mäßen Wirkstoffkombinationen in wässrige Systeme bzw. Tensidzubereitungen zur Reini gung der Haut und der Haare einzufügen. Emulsions according to the invention for the purposes of the present invention, e.g. B. in the form of a cream, a lotion, a cosmetic milk are advantageous and contain z. B. fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers, as they are usually used for such a type of formulation. It is also possible and advantageous for the purposes of the present invention to incorporate the active compound combinations according to the invention into aqueous systems or surfactant preparations for cleaning the skin and hair.
Es ist dem Fachmann natürlich bekannt, dass anspruchsvolle kosmetische Zusammen setzungen zumeist nicht ohne die üblichen Hilfs- und Zusatzstoffe denkbar sind. Darunter zählen beispielsweise Konsistenzgeber, Füllstoffe, Parfüm, Farbstoffe, Emulgatoren, zusätz liche Wirkstoffe wie Vitamine oder Proteine, Lichtschutzmittel, Stabilisatoren, Insek- tenrepellentien, Alkohol, Wasser, Salze, antimikrobiell, proteolytisch oder keratolytisch wirk same Substanzen usw. It is of course known to the person skilled in the art that sophisticated cosmetic compositions are mostly inconceivable without the customary auxiliaries and additives. These include, for example, consistency enhancers, fillers, perfumes, dyes, emulsifiers, additional active ingredients such as vitamins or proteins, sunscreens, stabilizers, insect repellants, alcohol, water, salts, antimicrobial, proteolytic or keratolytic substances, etc.
Mutatis mutandis gelten entsprechende Anforderungen an die Formulierung medizinischer Zubereitungen. Mutatis mutandis, corresponding requirements apply to the formulation of medical preparations.
Medizinische topische Zusammensetzungen im Sinne der vorliegenden Erfindung enthalten in der Regel ein oder mehrere Medikamente in wirksamer Konzentration. Der Einfachheit halber wird zur sauberen Unterscheidung zwischen kosmetischer und medizinischer Anwen dung und entsprechenden Produkten auf die gesetzlichen Bestimmungen der Bundesrepub lik Deutschland verwiesen (z. B. Kosmetikverordnung, Lebensmittel- und Arzneimittelge setz). Medical topical compositions for the purposes of the present invention generally contain one or more medicaments in effective concentrations. For the sake of simplicity, reference is made to the statutory provisions of the Federal Republic of Germany (e.g. Cosmetics Ordinance, Food and Drug Act) to clearly distinguish between cosmetic and medical applications and corresponding products.
Es ist dabei ebenfalls von Vorteil, die erfindungsgemäßen Wirkstoffkombinationen als Zu satzstoff zu Zubereitungen zu geben, die bereits andere Wirkstoffe für andere Zwecke ent halten. It is also advantageous to add the active ingredient combinations according to the invention as an additive to preparations which already contain other active ingredients for other purposes.
Entsprechend können kosmetische oder topische dermatologische Zusammensetzungen im Sinne der vorliegenden Erfindung, je nach ihrem Aufbau, beispielsweise verwendet werden als Hautschutzcreme, Reinigungsmilch, Sonnenschutzlotion, Nährcreme, Tages- oder Nachtcreme usw. Es ist gegebenenfalls möglich und vorteilhaft, die erfindungsgemäßen Zu sammensetzungen als Grundlage für pharmazeutische Formulierungen zu verwenden. Zur Anwendung werden die kosmetischen und dermatologischen Zubereitungen erfindungs gemäß in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausreichen der Menge aufgebracht. Accordingly, cosmetic or topical dermatological compositions within the meaning of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sun protection lotion, nutritional cream, day or night cream, etc. It is optionally possible and advantageous to use the compositions according to the invention as a basis for to use pharmaceutical formulations. For use, the cosmetic and dermatological preparations are applied according to the invention to the skin and / or hair in a sufficient amount in the manner customary for cosmetics.
Besonders bevorzugt sind solche kosmetischen und dermatologischen Zubereitungen, die in der Form eines Sonnenschutzmittels vorliegen. Vorteilhaft können diese zusätzlich minde stens einen weiteren UVA-Filter und/oder mindestens einen weiteren UVB-Filter und/oder mindestens ein anorganisches Pigment, bevorzugt ein anorganisches Mikropigment, enthal ten. Those cosmetic and dermatological preparations which are in the form of a sunscreen agent are particularly preferred. These can advantageously also contain at least one further UVA filter and / or at least one further UVB filter and / or at least one inorganic pigment, preferably an inorganic micropigment.
Die kosmetischen und dermatologischen Zubereitungen können erfindungsgemäß kosmeti sche Hilfsstoffe enthalten, wie sie üblicherweise in solchen Zubereitungen verwendet wer den, z.B. Konservierungsmittel, Bakterizide, Parfüme, Substanzen zum Verhindern des Schäumens, Farbstoffe, Pigmente, die eine färbende Wirkung haben, Verdickungsmittel, an feuchtende und/oder feuchhaltende Substanzen, Fette, Öle, Wachse oder andere übliche Bestandteile einer kosmetischen oder dermatologischen Formulierung wie Alkohole, Polyole, Polymere, Schaumstabilisatoren, Elektrolyte, organische Lösungsmittel oder Silikonderivate. According to the invention, the cosmetic and dermatological preparations can contain cosmetic auxiliaries such as are customarily used in such preparations, for example preservatives, bactericides, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, and moisturizers / or moisture-retaining substances, fats, oils, waxes or other common constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
Ein zusätzlicher Gehalt an üblichen Antioxidantien ist im Allgemeinen bevorzugt. Erfindungs gemäß können als günstige Antioxidantien alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden. An additional content of customary antioxidants is generally preferred. According to the invention, all antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.
Die Menge der vorgenannten Antioxidantien (eine oder mehrere Verbindungen) in den Zube reitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugt 0,05 - 20 Gew.-%, insbesondere 1 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung. The amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight the preparation.
Sofern die kosmetische oder dermatologische Zubereitung im Sinne der vorliegenden Erfin dung eine Lösung oder Emulsion oder Dispersion darstellt, können als Lösungsmittel ver wendet werden: If the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, the following solvents can be used:
Wasser oder wässrige Lösungen Water or aqueous solutions
Öle, wie Triglyceride der Caprin- oder der Caprylsäure, vorzugsweise aber Rizinusöl; Fette, Wachse und andere natürliche und synthetische Fettkörper, vorzugsweise Ester von Fettsäuren mit Alkoholen niedriger C-Zahl, z.B. mit Isopropanol, Propylenglykol oder Glycerin, oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fettsäuren; Oils, such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, for example with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids;
Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Etha nol, Isopropanol, Propylenglykol, Glycerin, Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diet- hylenglykolmonomethyl- oder -monoethylether und analoge Produkte. Alcohols, diols or polyols with a low carbon number and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl ether or analogues Products.
Insbesondere werden Gemische der vorstehend genannten Lösungsmittel verwendet. Bei alkoholischen Lösungsmitteln kann Wasser ein weiterer Bestandteil sein. In particular, mixtures of the abovementioned solvents are used. In the case of alcoholic solvents, water can be another component.
Sofern die kosmetische oder dermatologische Zubereitung im Sinne der vorliegenden Erfin dung eine Lösung oder Emulsion oder Dispersion darstellt, können als Lösungsmittel ver wendet werden: If the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, the following solvents can be used:
Wasser oder wässrige Lösungen Water or aqueous solutions
Öle, wie Triglyceride der Caprin- oder der Caprylsäure, vorzugsweise aber Rizinusöl; Fette, Wachse und andere natürliche und synthetische Fettkörper, vorzugsweise Ester von Fettsäuren mit Alkoholen niedriger C-Zahl, z.B. mit Isopropanol, Propylenglykol oder Glycerin, oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fettsäuren; Oils, such as triglycerides of capric or caprylic acid, but preferably castor oil; Fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerine, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids;
Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Etha nol, Isopropanol, Propylenglykol, Glycerin, Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diet- hylenglykolmonomethyl- oder -monoethylether und analoge Produkte. Alcohols, diols or polyols with a low carbon number and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl ether or analogues Products.
Insbesondere werden Gemische der vorstehend genannten Lösungsmittel verwendet. Bei alkoholischen Lösungsmitteln kann Wasser ein weiterer Bestandteil sein. In particular, mixtures of the abovementioned solvents are used. In the case of alcoholic solvents, water can be another component.
Als Treibmittel für aus Aerosolbehältern versprühbare kosmetische und/oder dermato logische Zubereitungen im Sinne der vorliegenden Erfindung sind die üblichen bekannten leichtflüchtigen, verflüssigten Treibmittel, beispielsweise Kohlenwasserstoffe (Propan, Butan, Isobutan) geeignet, die allein oder in Mischung miteinander eingesetzt werden können. Auch Druckluft ist vorteilhaft zu verwenden. Natürlich weiß der Fachmann, dass es an sich nichttoxische Treibgase gibt, die grund sätzlich für die Verwirklichung der vorliegenden Erfindung in Form von Aerosol präparaten geeignet wären, auf die aber dennoch wegen bedenklicher Wirkung auf die Umwelt oder sonstiger Begleitumstände verzichtet werden sollte, insbesondere Fluorkohlenwasserstoffe und Fluorchlorkohlenwasserstoffe (FCKW). Suitable propellants for cosmetic and / or dermatological preparations which can be sprayed from aerosol containers within the meaning of the present invention are the customary, highly volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be used alone or in a mixture with one another. It is also advantageous to use compressed air. Of course, the person skilled in the art knows that there are propellant gases which are nontoxic per se, which would be suitable in principle for the implementation of the present invention in the form of aerosol preparations, but which should nevertheless be avoided because of their harmful effects on the environment or other accompanying circumstances, in particular fluorocarbons and Chlorofluorocarbons (CFCs).
Kosmetische Zubereitungen im Sinne der vorliegenden Erfindung können auch als Gele vor liegen, die neben einem wirksamen Gehalt an erfindungsgemäßen Wirkstoffkombinationen und dafür üblicherweise verwendeten Lösungsmitteln, bevorzugt Wasser, noch organische Verdickungsmittel, z.B. Gummiarabikum, Xanthangummi, Natriumalginat, Cellulose- Derivate, vorzugsweise Methylcellulose, Hydroxymethylcellulose, Hydroxyethylcellulose, Hydroxypropylcellulose, Hydroxypropylmethylcellulose oder anorganische Verdickungsmittel, z. B. Aluminiumsilikate wie beispielsweise Bentonite, oder ein Gemisch aus Polyethylengly kol und Polyethylenglykolstearat oder -distearat, enthalten. Das Verdickungsmittel ist in dem Gel z.B. in einer Menge zwischen 0,1 und 30 Gew.-%, bevorzugt zwischen 0,5 und 15 Gew.-%, enthalten. Cosmetic preparations within the meaning of the present invention can also be in the form of gels which, in addition to an effective content of active ingredient combinations according to the invention and solvents usually used for this, preferably water, also organic thickeners, e.g. gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, hydroxymethyl cellulose , Hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose or inorganic thickeners, e.g. B. aluminum silicates such as bentonite, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate contain. The thickening agent is contained in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight.
Es ist erfindungsgemäß vorteilhaft, außer den erfindungsgemäßen Kombinationen weitere öllösliche UVA-Filter und/oder UVB-Filter in der Lipidphase und/oder weitere wasserlösliche UVA-Filter und/oder UVB-Filter in der wässrigen Phase einzusetzen. It is advantageous according to the invention, in addition to the combinations according to the invention, to use further oil-soluble UVA filters and / or UVB filters in the lipid phase and / or further water-soluble UVA filters and / or UVB filters in the aqueous phase.
Vorteilhaft können die Lichtschutzformulierungen erfindungsgemäß weitere Substanzen ent halten, die UV-Strahlung im UVB-Bereich absorbieren, wobei die Gesamtmenge der Fil tersubstanzen z.B. 0,1 Gew.-% bis 30 Gew.-%, vorzugsweise 0,5 bis 10 Gew.-%, insbe sondere 1 bis 6 Gew.-% beträgt, bezogen auf das Gesamtgewicht der Zubereitungen, um kosmetische Zubereitungen zur Verfügung zu stellen, die die Haut vor dem gesamten Be reich der ultravioletten Strahlung schützen. Sie können auch als Sonnenschutzmittel dienen. According to the invention, the light protection formulations can advantageously contain further substances which absorb UV radiation in the UVB range, the total amount of the filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight. %, in particular 1 to 6% by weight, based on the total weight of the preparations, in order to provide cosmetic preparations which protect the skin from the entire range of ultraviolet radiation. They can also serve as sunscreens.
Experimente zur Stabilität von Ubidecarenol in Kombination mit verschiedenen Emul- qatoren: Experiments on the stability of ubidecarenol in combination with different emulsifiers:
Überraschend wurde gefunden, dass einige anionische O/W Emulgatoren (z.B. Kalium- Cetearylphosphat) Ubiquinol besser stabilisieren als andere anionische Emulgatoren (z.B. SLES). It was surprisingly found that some anionic O / W emulsifiers (e.g. potassium cetearyl phosphate) stabilize ubiquinol better than other anionic emulsifiers (e.g. SLES).
Hierzu wurden die unten in der Tabelle genannten Rohstoffe in 30 mL Gläser gegeben & zugeschraubt. Anschließend wurde per Hand kurz (ca. 15 min) und intensiv geschüttelt, da mit die Komponenten vermischt werden. Anschließend wurde für 3 Tage im Wärmeschrank gelagert.
Figure imgf000010_0001
For this purpose, the raw materials listed in the table below were put into 30 mL jars and screwed on. This was followed by brief (approx. 15 min) and intensive shaking by hand, since the components are mixed with it. It was then stored in the heating cabinet for 3 days.
Figure imgf000010_0001
Dabei zeigte sich beim Ansatz mit SLES die stärkste und beim Kaliumcatylphosphat die schwächste Gelbfärbung. The strongest yellow coloration was found in the approach with SLES and the weakest in the case of potassium catyl phosphate.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzu schränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders an gegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zuberei tungen bezogen.
Figure imgf000011_0001
The following examples are intended to illustrate the present invention without restricting it. Unless otherwise stated, all quantities, proportions and percentages are based on the weight and the total amount or the total weight of the preparations.
Figure imgf000011_0001
Figure imgf000012_0001
pH 5,5 -6,5
Figure imgf000012_0001
pH 5.5-6.5
Figure imgf000013_0001
pH 6, 2-7, 2
Figure imgf000013_0001
pH 6.2-7.2
Figure imgf000014_0001
pH 5, 5-6, 5
Figure imgf000014_0001
pH 5.5-6.5

Claims

Patentansprüche Claims
1. Wirkstoffkombinationen, umfassend a) Ubidecarenol und b) einen oder mehrere Phosphatemulgatoren oder Sulfatemulgatoren. 1. Active ingredient combinations, comprising a) ubidecarenol and b) one or more phosphate emulsifiers or sulfate emulsifiers.
2. Kosmetische oder dermatologische Zubereitungen, insbesondere in Form von O/W- Emulsionen, mit einem Gehalt Wirkstoffkombinationen gemäß Anspruch 1. 2. Cosmetic or dermatological preparations, in particular in the form of O / W emulsions, containing combinations of active ingredients according to claim 1.
3. Wirkstoffkombinationen nach Anspruch 1 oder Zubereitungen nach Anspruch 2, dadurch gekennzeichnet, dass als Phosphat- bzw Sulfatemulgator ein oder mehrere aus der Gruppe Triceteareth-4 Phosphat, Cetylphosphat, Lecithin, hydriertes Lecithin, Kaliumcetylphosphat, Trilaureth-4 Phosphat, Laureth-4 Phosphat, Sodium Dihydroxy- cetyl Phosphate, Trioleth-8 Phosphate, Natriumcetearylsulfat gewählt wird oder wer den. 3. Active ingredient combinations according to claim 1 or preparations according to claim 2, characterized in that the phosphate or sulfate emulsifier is one or more from the group triceteareth-4 phosphate, cetyl phosphate, lecithin, hydrogenated lecithin, potassium cetyl phosphate, trilaureth-4 phosphate, laureth-4 phosphate , Sodium dihydroxycetyl phosphate, trioleth-8 phosphate, sodium cetearyl sulfate is chosen or who the.
4. Wirkstoffkombinationen oder Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass das molare Verhältnis von Ubidecarenol einerseits zu der molaren Summe eines oder mehrerer Phosphatemulgatoren oder Sulfatemulgato ren andererseits aus dem Bereich von 100 : 1 bis 1 : 1000 , bevorzugt 50 : 1 bis 1 :4. Active ingredient combinations or preparations according to one of the preceding claims, characterized in that the molar ratio of ubidecarenol on the one hand to the molar sum of one or more phosphate emulsifiers or sulfate emulsifiers on the other hand from the range of 100: 1 to 1: 1000, preferably 50: 1 to 1 :
500, insbesondere bevorzugt 20 : 1 bis 1 : 200 gewählt wird. 500, particularly preferably 20: 1 to 1: 200 is selected.
5. Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass Ubidecarenol, in Konzentrationen von 0,001 - 10,00 Gew.-%, bevorzugt 0,05 - 5,00 Gew.-%, besonders bevorzugt 0,1 - 3,00 Gew.-%, jeweils bezogen auf das Ge samtgewicht der Zusammensetzung, vorliegt. 5. Preparations according to one of the preceding claims, characterized in that ubidecarenol, in concentrations of 0.001-10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-3.00 % By weight, each based on the total weight of the composition.
6. Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass ein oder mehrere Phosphatemulgatoren in Konzentrationen von insgesamt 0,001 - 10,00 Gew.-%, bevorzugt 0,05 - 5,00 Gew.-%, besonders bevorzugt 0,1 -6. Preparations according to one of the preceding claims, characterized in that one or more phosphate emulsifiers in total concentrations of 0.001-10.00% by weight, preferably 0.05-5.00% by weight, particularly preferably 0.1-
3,00 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, vorliegt oder vorliegen. Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass ein oder mehrere Sulfatemulgatoren in Konzentrationen von insgesamt 0,001 - 1,00 Gew.-%, bevorzugt 0,05 - 0,50 Gew.-%, besonders bevorzugt 0,10 — 3.00% by weight, based in each case on the total weight of the composition, is or are present. Preparations according to one of the preceding claims, characterized in that one or more sulfate emulsifiers in total concentrations of 0.001-1.00% by weight, preferably 0.05-0.50% by weight, particularly preferably 0.10% by weight,
0,30 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, vorliegt oder vorliegen. 0.30% by weight, based in each case on the total weight of the composition, is or are present.
PCT/EP2020/080057 2019-11-26 2020-10-26 Active substance combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates, and cosmetic or dermatological preparations containing such active substance combinations WO2021104777A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102019218244.5 2019-11-26
DE102019218244.5A DE102019218244A1 (en) 2019-11-26 2019-11-26 Active ingredient combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates and cosmetic or dermatological preparations containing such active ingredient combinations

Publications (1)

Publication Number Publication Date
WO2021104777A1 true WO2021104777A1 (en) 2021-06-03

Family

ID=73020222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2020/080057 WO2021104777A1 (en) 2019-11-26 2020-10-26 Active substance combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates, and cosmetic or dermatological preparations containing such active substance combinations

Country Status (2)

Country Link
DE (1) DE102019218244A1 (en)
WO (1) WO2021104777A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144325A (en) 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning
US4248861A (en) 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
WO2003039508A1 (en) * 2001-11-07 2003-05-15 Beiersdorf Ag Low-viscosity, sprayable w/o emulsions
EP1386905A1 (en) * 2001-05-09 2004-02-04 Kaneka Corporation Stable solution of reduced coenzyme q
EP1475363A1 (en) * 2002-01-18 2004-11-10 Kaneka Corporation Method for stabilizing reduced coenzyme q 10 and composition therefor
WO2017045034A1 (en) 2015-09-17 2017-03-23 Pharmako Biotechnologies Pty Limited Ubiquinone and ubiquinol compositions, and methods relating thereto
CN109172448A (en) * 2018-10-12 2019-01-11 广州市雅彩盛生物科技有限公司 A kind of skin care item and preparation method thereof with anti-blue light action

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19806947A1 (en) * 1998-02-19 1999-08-26 Beiersdorf Ag Combination of (acyl) carnitine and (hydro)quinone for use in skin care, effective e.g. against light-induced damage and inflammation
DE102014223568A1 (en) * 2014-11-19 2016-05-19 Beiersdorf Ag Preparations containing ascorbic acid, ubidecarenone and mixtures of sodium stearoylglutamate and / or cetylstearylsulfate in combination with glycerylstearate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144325A (en) 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning
US4248861A (en) 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
EP1386905A1 (en) * 2001-05-09 2004-02-04 Kaneka Corporation Stable solution of reduced coenzyme q
WO2003039508A1 (en) * 2001-11-07 2003-05-15 Beiersdorf Ag Low-viscosity, sprayable w/o emulsions
EP1475363A1 (en) * 2002-01-18 2004-11-10 Kaneka Corporation Method for stabilizing reduced coenzyme q 10 and composition therefor
WO2017045034A1 (en) 2015-09-17 2017-03-23 Pharmako Biotechnologies Pty Limited Ubiquinone and ubiquinol compositions, and methods relating thereto
CN109172448A (en) * 2018-10-12 2019-01-11 广州市雅彩盛生物科技有限公司 A kind of skin care item and preparation method thereof with anti-blue light action

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 5 October 2016 (2016-10-05), ANONYMOUS: "Hydrating & Firming Eye Mask", XP055759785, Database accession no. 4327537 *

Also Published As

Publication number Publication date
DE102019218244A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
DE60025147T2 (en) Cosmetic composition and uses
DE4320871C2 (en) Cosmetic and dermatological preparations containing delta-aminolevulinic acid
DE4242876A1 (en) Synergistic combinations of active ingredients for cosmetic and / or dermatological care of the skin and / or the appendages of the skin
EP2906196B1 (en) Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
DE69724629T2 (en) COMPOSITIONS AND THEIR USE
WO1997007821A1 (en) Antipruriginous cosmetic and/or pharmaceutical compositions consisting of one or several light local anaesthetics and one or several astringent substances
EP2265245B1 (en) Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-ispropyl-5-methylcyclohexane carboxamide for the reduction of erythema
EP3524236A1 (en) Use of licochalchone a or an extract containing licochalchone a from radix glycyrrhizae inflatae against skin aging
WO1994018942A1 (en) Synergistic combinations of sunscreening substances, cosmetic and dermatological compositions containing such combinations
EP3024433A1 (en) Transparent sunscreen compositions and use thereof
WO2009115164A2 (en) Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexane carboxamide comprising menthoxypropane diol
WO2021104777A1 (en) Active substance combinations of ubiquinol and one or more emulsifiers from the group of phosphates and sulfates, and cosmetic or dermatological preparations containing such active substance combinations
WO2021104770A1 (en) Active substance combinations of ubichinol und glyceryl stearate citrate and cosmetic or dermatological preparations containing said active substance combinations
EP1889597A1 (en) Active agent combinations of an ascorbyl compound and hydrogenated lecithin
DE102020206961A1 (en) Use of one or more extracts from magnolia bark as an antioxidant or radical scavenger in cosmetic or dermatological preparations, in particular to prevent oxidative stress caused by visible light
WO2007096090A1 (en) Active substance combinations of hydroxymatairesinol, phenoxyethanol and, if desired, glycerin
WO2021104773A1 (en) Active substance combinations of ubichinol und hyaluronic acid and cosmetic or dermatological preparations containing said active substance combinations
EP4065238A1 (en) Active substance combinations of ubichinol and creatine and cosmetic or dermatological preparations containing said active substance combinations
EP2695599A1 (en) Cosmetic or dermatological preparations with a content of urea and a content of licochalcone A or an aqueous extract of radix glycyrrhizae inflatae, containing licochalcone A
WO2021104772A1 (en) Active substance combinations of ubiquinol and carrageenan and cosmetic or dermatological preparations containing said active substance combinations
WO2016169798A1 (en) Use of hibifolin against skin aging
DE102012218116A1 (en) Use of ingredients of extracts from seeds of jackfruit tree (Artocarpus heterophyllus) in cosmetic or dermatological preparations for prophylaxis the treatment of e.g. sensitive skin, itching and dry skin
DE102005048778A1 (en) Cosmetic formulations to improve the appearance of the skin
WO2016034400A1 (en) Use of gossypetin and/or gossypin against skin aging
DE102005048779A1 (en) Cosmetic formulations for improving skin barrier function

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20797465

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 20797465

Country of ref document: EP

Kind code of ref document: A1